The Team

---

 Robert is an experienced executive with over 30 years of leadership within the healthcare and laboratory industry. He has held various executive leadership positions over his decorated career, most recently as the Executive Vice President of Operations at Pathonostics. Prior to that role, Robert was the Vice President of Operations for Plus Diagnostics.  He has successfully started several companies, leading them through growth and acquisition stages.  Robert is a licensed histotechnologist (HT17899) and holds a Qualification in Immunohistochemistry (QIHC) from the American Society for Clinical Pathology (ASCP). 

  Jason has a strong track record of building and growing businesses during a distinguished career spanning nearly 25 years in healthcare. He has led healthcare service companies ranging in size from $35 million to $500 million in revenue. Prior to launching EmeritusDX, Jason was the Vice President of Operations for NeoGenomics, the nation's largest oncology reference laboratory. Prior to that he held several executive roles as Vice President of Operations for LabCorp’s Integrated Oncology and Dianon Divisions and later as Vice President of Operations for Pathnostics. Jason also founded Morningstar Laboratories, a pharma services company that was sold to a private equity group.  Jason received his bachelor’s of science degree in Economics from the Ohio State University and his MBA from the University of La Verne.  

Dr. Funari's impressive 20-year career has centered on integrating genomic technologies into precision medicine, particularly concerning hematologic and solid tumors. He is licensed as a Clinical Genetic Molecular Biologist Scientist (CGMBS) by the California Department of Health Care Services.   

Previously, Dr. Funari held the position of Chief Scientific Officer at Imagia Canexia Health, where he spearheaded the development of pioneering tumor profiling laboratory developed tests (LDTs) for both clinical and commercial use. Before this role, he contributed significantly as the Chief Scientific Officer at NeoGenomics, overseeing the successful launch of several comprehensive genomic panels(CGP). Additionally, he transformed existing PCR products into commercially vital panels that elevated patient care. Finally in his 10 years at Cedars Sinai and UCLA as an associate professor, he co-authored over 35 peer reviewed publications in industry leading journals(eg NEJM, Science, Nature Genetics, Nature Immunology, Cell host and Microbe,etc) with over 5500 citations. He also helped to usher genomics and bioinformatics into precession medicine as a principal educator in Grand rounds and fellowship programs. 

 Dr. Tsai completed his combined MD and PhD program (pharmacology and toxicology) at UC Irvine, then went to UCLA for his Anatomic and Clinical Pathology residency program as well as fellowships in Surgical Pathology and Cytopathology. Dr. Tsai is board-certified in Anatomic Pathology, Clinical Pathology, and Cytopathology. He holds New York certificate of qualification in Oncology, Genetic Testing, Virology, Bacteriology, Mycology, Toxicology, Cytology, and Histology. He has authored many publications in peer-reviewed journals, incl. a book chapter in Handbook of Immunohistochemistry and In situ Hybridization of Human Carcinomas.* Previously, Dr. Tsai was the laboratory director of Human Longevity Inc. and its Oncology Division (before acquisition by NeoGenomics). Dr. Tsai was also responsible for the medical directorship of many urologic groups as well as the Medical Director of Houston Plus Diagnostics Laboratory. 

   Alli Iredale is an accomplished executive with over 23 years of experience in sales leadership and business development. Known for her exceptional achievements in leading sales teams, driving sales growth, and building solid business partnerships, Alli has consistently demonstrated her expertise in managing diverse sales territories and achieving revenue goals.  In her previous roles as Director of Sales for Pathnostics, she oversaw a team of eleven territory managers across the West and Midwest regions. Previously, as Vice President of Sales Marketing and Business Development at Cabot Lab, she successfully built and trained a national sales team while developing comprehensive marketing strategies for various healthcare providers.  Allison holds a Bachelor of Science in Business Administration and Communications from Kutztown University in Pennsylvania.